Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance
Chunjie Huang, Paniz Azizi, Masoud Vazirzadeh, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
TRIM proteins in hepatocellular carcinoma
Kan Lu, Yonglong Pan, Zhao Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 32
PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities
Mohammed Ageeli Hakami, Ali Hazazi, Farhan R. Khan, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155019-155019
Closed Access | Times Cited: 21
The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics
Zhao Guo, Chuan Liu, Xin Wen, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107881-107881
Closed Access | Times Cited: 41
The roles of E3 ligases in Hepatocellular carcinoma.
Zongdong Yu, Hong Li, Jie Zhu, et al.
PubMed (2022) Vol. 12, Iss. 3, pp. 1179-1214
Closed Access | Times Cited: 25
E3 ubiquitin ligase TRIM31: A potential therapeutic target
Nian-Hua Deng, Zhen Tian, Ying-Jiao Zou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116846-116846
Open Access | Times Cited: 4
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
Mickaël Jouve, Rodolphe Carpentier, Sarra Kraiem, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5557-5557
Open Access | Times Cited: 10
Mesenchymal stem cell extracellular vesicle vascularization bioactivity and production yield are responsive to cell culture substrate stiffness
Emily H. Powsner, Stephanie M. Kronstadt, Kristin Nikolov, et al.
Bioengineering & Translational Medicine (2025) Vol. 10, Iss. 3
Open Access
Targeting p53-p21 signaling to enhance mesenchymal stem cell regenerative potential
Ahsas Goyal, Muhammad Afzal, Nawaid Hussain Khan, et al.
Regenerative Therapy (2025) Vol. 29, pp. 352-363
Closed Access
Knockdown of circ_HIPK3 inhibits tumorigenesis of hepatocellular carcinoma via the miR-582-3p/DLX2 axis
Hongbin Zhang, Qun Dai, Lihua Zheng, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 533, Iss. 3, pp. 501-509
Closed Access | Times Cited: 24
Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders
Austin Lui, Timothy Do, Omar Alzayat, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 426-426
Open Access | Times Cited: 3
MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC
Ting Zou, Yan Gao, Mingrong Qie
Annals of Translational Medicine (2021) Vol. 9, Iss. 2, pp. 125-125
Open Access | Times Cited: 18
TRIM31: A molecule with a dual role in cancer
Yafei Guo, Ping Lin, Yimin Hua, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Deciphering roles of TRIMs as promising targets in hepatocellular carcinoma: current advances and future directions
Jie Zhang, Yuting Zhou, Jiao Feng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115538-115538
Open Access | Times Cited: 6
Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling
Ziang Yang, Bei Xu, Sheng Wu, et al.
Human Cell (2022) Vol. 35, Iss. 6, pp. 1797-1812
Closed Access | Times Cited: 9
MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular carcinoma
Somaia Shehab-Eldeen, Mohamed F. Metwaly, Safa M. Saber, et al.
Digestive and Liver Disease (2022) Vol. 55, Iss. 2, pp. 283-290
Closed Access | Times Cited: 8
Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma
Wenlei Dong, Chao Zhan
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 4, pp. 1915-1926
Open Access | Times Cited: 8
TRIM50 Inhibits Proliferation and Metastasis of Gastric Cancer via Promoting β-Catenin Degradation
Rongzhou Li, Peng Xu, Xiaosheng Jin, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 5
COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma
Weidan Fang, Yu Gan, Ling Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
miR-29c-3p represses the angiogenesis of esophageal squamous cell carcinoma by targeting SERPINH1 to regulate the Wnt signaling pathway
Desheng Wei, Zhifeng Ma, Ting Zhu, et al.
Acta Cirúrgica Brasileira (2023) Vol. 38
Open Access | Times Cited: 1
Tripartite motif family – its role in tumor progression and therapy resistance: a review
Yongqi Zhang, Ying Guan, Shuxiang Wang, et al.
Current Opinion in Oncology (2024) Vol. 36, Iss. 2, pp. 102-114
Closed Access
Exploring miRNA Biomarkers in Major Depressive Disorder: A Molecular Medicine Perspective
Cătălin Prodan-Bărbulescu, Laura Andreea Ghenciu, Edward Paul Şeclăman, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 10, pp. 10846-10853
Open Access
Page 1

Scroll to top